Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease
85 results
1 - 85
Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease
Azathioprine and 6‐mercaptopurine for maintenance of surgically‐induced remission in Crohn's disease
Adalimumab for maintenance of remission in Crohn's disease
Methotrexate for maintenance of remission in Crohn's disease
Probiotics for maintenance of remission in Crohn's disease
Budesonide for maintenance of remission in Crohn's disease
Budesonide for maintenance of remission in Crohn's disease
Enteral nutrition for maintenance of remission in Crohn's disease
Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease
Corticosteroids for maintenance of remission in Crohn's disease
Vedolizumab for induction and maintenance of remission in Crohn's disease
Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease
Enteral nutrition for maintenance of remission in Crohn's disease
Tumor necrosis factor‐alpha antibody for maintenance of remission in Crohn's disease
Anti‐tuberculous therapy for maintenance of remission in Crohn's disease
Infliximab for maintenance of medically induced remission in Crohn's disease
Infliximab for maintenance of medically‐induced remission in Crohn's disease
Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in Crohn's disease
Antibiotics for induction and maintenance of remission in Crohn's disease
Oral 5‐aminosalicylic acid for maintenance of medically‐induced remission in Crohn's disease
Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease
Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease
Interventions for maintenance of surgically induced remission in Crohn’s disease: a network meta‐analysis
Azathioprine or 6-mercaptopurine for maintaining remission in Crohn's disease
Crohn’s disease
6‐thioguanine nucleotide monitoring in azathioprine and mercaptopurine monotherapy for the treatment of inflammatory bowel disease
Methotrexate for induction of remission in ulcerative colitis
Methotrexate for maintenance of remission in ulcerative colitis
Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease
Certolizumab pegol for induction of remission in Crohn's disease
Cannabis for the treatment of Crohn's disease
Tumor necrosis factor‐alpha antagonists for treatment of pediatric Crohn’s disease
Budesonide for induction of remission in Crohn's disease
Vedolizumab for induction and maintenance of remission in ulcerative colitis
Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease
Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis
Dietary interventions for induction and maintenance of remission in inflammatory bowel disease

